Chapter 8 The Role of NKT Cells in Tumor Immunity
- 1 January 2008
- book chapter
- Published by Elsevier in Advances in Cancer Research
- Vol. 101, 277-348
- https://doi.org/10.1016/s0065-230x(08)00408-9
Abstract
No abstract availableKeywords
This publication has 333 references indexed in Scilit:
- IL-21 and TGF-β are required for differentiation of human TH17 cellsNature, 2008
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote MetastasisCancer Cell, 2008
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Peripheral blood IFN‐γ‐secreting Vα24+Vβ11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor loadInternational Journal of Cancer, 2005
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004
- Mechanism of CD1d-restricted natural killer T cell activation during microbial infectionNature Immunology, 2003
- Inflammation and cancerNature, 2002
- CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lungNature Medicine, 2002
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992